Research use only. All compounds are for laboratory research. Not for human or veterinary use. 18+.

Vantage Aminos · Research

Research

Verification methods, handling protocols, and compound documentation — written for researchers. Research use only.

June 19, 2026

How to Vet a Research Peptide Vendor

How to Vet a Research Peptide Vendor The research peptide market is uneven. Quality, documentation, and business practices vary widely between suppliers, and the burden of verification falls on the buyer. This guide outlines the criteria a research buyer can use to evaluate a vendor before placing an order. 1. A batch-specific Certificate of Analysis […]

June 19, 2026

Kisspeptin vs HCG: How the Research Compares

Kisspeptin vs HCG: How the Research Compares Kisspeptin and HCG both appear in reproductive-endocrinology research, but they act at opposite ends of the hypothalamic-pituitary-gonadal axis: upstream signaling versus a downstream gonadal receptor. At a glance Property Kisspeptin HCG Class Synthetic peptide (Kisspeptin-10) Glycoprotein hormone Primary research target KISS1R (upstream of GnRH) LH/CG receptor (gonadal) Research […]

June 19, 2026

BPC-157 vs GHK-Cu: How the Research Compares

BPC-157 vs GHK-Cu: How the Research Compares BPC-157 and GHK-Cu both appear across tissue-repair research, but one is a pentadecapeptide studied in angiogenesis and connective-tissue models and the other a copper tripeptide studied in dermal and extracellular-matrix models. At a glance Property BPC-157 GHK-Cu Class Synthetic pentadecapeptide Copper tripeptide (Gly-His-Lys-Cu) Primary research target NO / […]

June 19, 2026

Tesofensine vs 5-Amino-1MQ: How the Research Compares

Tesofensine vs 5-Amino-1MQ: How the Research Compares Tesofensine and 5-Amino-1MQ are both studied in metabolic and appetite-related research, but they act through entirely different mechanisms: central monoamine reuptake versus a metabolic enzyme. At a glance Property Tesofensine 5-Amino-1MQ Class Triple monoamine reuptake inhibitor Small-molecule NNMT inhibitor Primary research target DA / NE / 5-HT transporters […]

June 19, 2026

MOTS-c vs 5-Amino-1MQ: How the Research Compares

MOTS-c vs 5-Amino-1MQ: How the Research Compares MOTS-c and 5-Amino-1MQ are both studied in metabolic research, but one is a mitochondrial-derived peptide and the other a small-molecule enzyme inhibitor with distinct targets. At a glance Property MOTS-c 5-Amino-1MQ Class Mitochondrial-derived peptide Small-molecule NNMT inhibitor Primary research target AMPK / metabolic homeostasis NNMT enzyme Research domain […]

June 19, 2026

Tesamorelin vs Ipamorelin: How the Research Compares

Tesamorelin vs Ipamorelin: How the Research Compares Tesamorelin and Ipamorelin are both studied in growth-hormone-axis research, but they act on two different arms of GH release: the GHRH receptor and the growth-hormone-secretagogue receptor. At a glance Property Tesamorelin Ipamorelin Class Stabilized GHRH analog Selective GH secretagogue (peptide) Primary research target GHRH receptor GHS-R1a (ghrelin receptor) […]

June 19, 2026

CJC-1295 With DAC vs No DAC: How the Research Compares

CJC-1295 with DAC vs CJC-1295 No DAC: How the Research Compares Both forms of CJC-1295 are synthetic analogs of growth-hormone-releasing hormone built on a modified GRF(1-29) sequence; the key research distinction is the Drug Affinity Complex (DAC) and its effect on half-life. At a glance Property CJC-1295 with DAC CJC-1295 No DAC Class GHRH(1-29) analog […]

June 19, 2026

PT-141 vs Melanotan 2 (MT-2): How the Research Compares

PT-141 vs MT-2 (Melanotan 2): How the Research Compares PT-141 (bremelanotide) and MT-2 (Melanotan II) are both synthetic cyclic heptapeptides studied as melanocortin-receptor agonists, but research interest centers on different receptor subtypes. At a glance Property PT-141 MT-2 (Melanotan 2) Class Synthetic cyclic heptapeptide Synthetic cyclic heptapeptide Primary research target MC3R / MC4R (central) MC1R […]

June 17, 2026

GLOW Complex: What the Research Shows

GLOW Complex: What the Research Shows GLOW Complex is a combination research blend of three peptides — GHK-Cu, BPC-157, and TB-500 — supplied at a 50:10:10 ratio (70 mg total). It is studied across tissue-repair, dermal extracellular-matrix, and angiogenesis research models. As a multi-component blend, GLOW Complex is a research preparation rather than a single […]

June 17, 2026

CJC-1295 (with DAC): What the Research Shows

CJC-1295 (with DAC): What the Research Shows CJC-1295 with DAC is a synthetic, long-acting analog of growth-hormone-releasing hormone (GHRH), built on a modified GRF(1-29) sequence and incorporating Drug Affinity Complex (DAC) technology that extends its research half-life. It is studied in preclinical research within the somatotropic axis and neuroendocrine signaling. In this modified form it […]